{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dalteparin+sodium&page=2", "query": { "intervention": "Dalteparin sodium", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 69, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dalteparin+sodium&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dalteparin+sodium&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-02T17:09:40.427Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01419977", "title": "Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sickle Cell Disease", "Vaso-occlusive Crisis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Dalteparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2011-05", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2015-02-16", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01419977" }, { "nct_id": "NCT00067093", "title": "Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Deep Vein Thrombosis" ], "interventions": [ { "name": "SanOrg34006", "type": "DRUG" }, { "name": "LMW heparin", "type": "DRUG" }, { "name": "Unfractionated heparin", "type": "DRUG" }, { "name": "Vitamin K antagonist (VKA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1452, "start_date": "2003-05", "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2011-04-06", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 24, "location_summary": "Denver, Colorado • Jacksonville, Florida • Melbourne, Florida + 21 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00067093" }, { "nct_id": "NCT00311090", "title": "Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Deep Venous Thrombosis" ], "interventions": [ { "name": "Idrabiotaparinux sodium", "type": "DRUG" }, { "name": "Idraparinux sodium", "type": "DRUG" }, { "name": "Avidin", "type": "DRUG" }, { "name": "Placebo (for Avidin)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 757, "start_date": "2006-04", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2016-03-21", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00311090" }, { "nct_id": "NCT02585713", "title": "Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebral Vein Thrombosis", "Deep Vein Thrombosis", "Gonadal Thrombosis", "Hepatic Thrombosis", "Malignant Neoplasm", "Mesenteric Thrombosis", "Metastatic Malignant Neoplasm", "Portal Vein Thrombosis", "Pulmonary Embolism", "Renal Vein Thrombosis", "Splenic Thrombosis", "Venous Thromboembolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Dalteparin", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2015-11-20", "completion_date": "2019-12-24", "has_results": true, "last_update_posted_date": "2020-08-04", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 18, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Evanston, Illinois + 15 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02585713" }, { "nct_id": "NCT02271113", "title": "Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "GMI-1271", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Enoxaparin Sodium (Lovenox®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlycoMimetics Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 32, "start_date": "2014-10", "completion_date": "2016-03", "has_results": false, "last_update_posted_date": "2018-02-27", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02271113" }, { "nct_id": "NCT00790335", "title": "Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Deep Vein Thrombosis", "Venous Thrombosis", "Postphlebitic Syndrome", "Venous Thromboembolism", "Post Thrombotic Syndrome" ], "interventions": [ { "name": "Recombinant tissue plasminogen activator (rt-PA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "16 Years to 75 Years" }, "enrollment_count": 692, "start_date": "2009-11", "completion_date": "2017-01", "has_results": true, "last_update_posted_date": "2018-03-29", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 56, "location_summary": "Glendale, Arizona • Orange, California • Stanford, California + 48 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Danbury", "state": "Connecticut" }, { "city": "Norwich", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00790335" }, { "nct_id": "NCT04372589", "title": "Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19", "Pneumonia" ], "interventions": [ { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Manitoba", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2020-05-20", "completion_date": "2021-05-17", "has_results": false, "last_update_posted_date": "2021-07-27", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 13, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Jefferson, Louisiana + 10 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Jefferson", "state": "Louisiana" }, { "city": "Portland", "state": "Maine" }, { "city": "Dearborn", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04372589" }, { "nct_id": "NCT00398216", "title": "A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Thrombosis", "Hip Replacement" ], "interventions": [ { "name": "DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 903, "start_date": "2006-05", "completion_date": "2007-06", "has_results": true, "last_update_posted_date": "2019-02-26", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 3, "location_summary": "Hartford, Connecticut • Sarasota, Florida • Austin, Texas", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00398216" }, { "nct_id": "NCT00967382", "title": "TIPPS: Thrombophilia in Pregnancy Prophylaxis Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pregnancy", "Thrombophilia", "Pregnancy Complications" ], "interventions": [ { "name": "dalteparin sodium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ottawa Hospital Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 292, "start_date": "2000-07", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2014-05-19", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 2, "location_summary": "St Louis, Missouri • Salt Lake City, Utah", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00967382" }, { "nct_id": "NCT02744092", "title": "Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer", "Venous Thromboembolism", "Deep Vein Thrombosis (DVT)", "Pulmonary Embolism (PE)", "Blood Clot" ], "interventions": [ { "name": "Rivaroxaban", "type": "DRUG" }, { "name": "Apixaban", "type": "DRUG" }, { "name": "Edoxaban", "type": "DRUG" }, { "name": "Dabigatran", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Dalteparin", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Fondaparinux", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance Foundation Trials, LLC.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 811, "start_date": "2016-12-13", "completion_date": "2021-02-22", "has_results": true, "last_update_posted_date": "2023-10-03", "last_synced_at": "2026-10-02T17:09:40.427Z", "location_count": 151, "location_summary": "Chula Vista, California • Fremont, California • Fresno, California + 104 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02744092" } ] }